Overview
- 37 inspections across 33 sites are on record.
- 97 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-05-20.
At a glance
Inspections
37
Sites
33
Observations
97
Career since
Aug 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Morton Grove Pharmaceuticals, Inc. | 20 May 2021 | Human Drugs | View 483 → |
| Pillar5 Pharma Inc | 21 Feb 2020 | Human Drugs | View 483 → |
| Delpharm Boucherville Canada Inc. | 11 Feb 2020 | Human Drugs | |
| Pharmaceutical Care Solutions | 24 Jan 2020 | Human Drugs | |
| Future Pak LLC | 12 Dec 2019 | Human Drugs | View 483 → |
Sites inspected
Morton Grove Pharmaceuticals, Inc.Morton Grove, United States1 insp.
Pillar5 Pharma IncArnprior, Canada1 insp.
Delpharm Boucherville Canada Inc.Boucherville, Canada1 insp.
Pharmaceutical Care SolutionsAnn Arbor, United States1 insp.
Future Pak LLCWixom, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Emilie Kahn4 shared
Jacob G Lutz2 shared
Robert J Ham2 shared
Robert M Barbosa2 shared
Michelle L Jones2 shared
Jeffrey D Meng2 shared
Nibin Varghese1 shared
Arsen Karapetyan1 shared
Justin A Boyd1 shared
Joseph T Madak1 shared
Full investigator report
Get the verbatim findings behind Sarah E Rhoades' 97 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site